Hospital consolidation, diagnostics roll-ups, and pharma platform builds are converging into a single investment narrative across Indian healthcare — and the scale of the opportunity is only beginning to be appreciated.
The Indian healthcare sector is at an inflection point. An ageing demographic, rising chronic disease burden, expanding insurance coverage, and growing medical tourism are creating sustained demand growth across every segment of the care continuum. The opportunity for investment bankers lies in the consolidation that naturally follows.
The hospital sector has seen significant consolidation in recent years, with Apollo, Max, and Fortis emerging as multi-hospital platforms. But the next wave of consolidation will be different — smaller regional hospital chains being acquired by national platforms, diagnostic chains being rolled up, and pharma companies building end-to-end capabilities through acquisition.
Platform building
At IIG, we have been active advisors in the healthcare sector for over a decade. Our approach to platform building is systematic: identify the target sub-sector, map the competitive landscape, identify consolidation candidates, and structure the acquisition and integration roadmap. The result is a platform that creates value through both revenue synergies and cost rationalisation.
Healthcare is not just a sector — it is a demographic imperative. The companies that build the platforms to serve India's healthcare needs will create generational value for their investors.